UPDATE 1-FDA approves BioCryst's intravenous flu drug
December 22, 2014 at 06:58 AM EST
Dec 22 (Reuters) - The U.S. Food and Drug Administration approved Biocryst Pharmaceuticals Inc's intravenous flu drug, sending the company's shares up nearly 10 percent in premarket trading.
